Adherence to interferon-beta treatment in patients with relapsing-remitting form of multiple sclerosis in Serbian district Sumadija

被引：0
|
作者：
Toncev, G. [1 ]
Vesic, K. [1 ]
Mijailovic, D. [1 ]
Drakulic, S. Miletic [1 ]
Matic, T. Boskovic [1 ]
Gavrilovic, A. [1 ]
Aleksic, D. [1 ]
Azanjac, A. [1 ]
Simovic, S. [1 ]
机构：
[1] Clin Ctr Kragujevac, Neurol Clin, Kragujevac, Serbia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1334
引用
收藏
页码：696 / 696
页数：1
相关论文
共 50 条
  • [21] Clinical and MRI predictors of response to interferon-beta and glatiramer acetate in relapsing-remitting multiple sclerosis patients
    Romeo, M.
    Martinelli-Boneschi, F.
    Rodegher, M.
    Esposito, F.
    Martinelli, V.
    Comi, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (07) : 1060 - 1067
  • [22] Effect of genetic polymorphisms on therapeutic response in multiple sclerosis relapsing-remitting patients treated with interferon-beta
    Martinez-Aguilar, Laura
    Perez-Ramirez, Cristina
    del Mar Maldonado-Montoro, Maria
    Isabel Carrasco-Campos, Maria
    Membrive-Jimenez, Cristina
    Martinez-Martinez, Fernando
    Garcia-Collado, Carlos
    Angel Calleja-Hernandez, Miguel
    Carmen Ramirez-Tortosa, Maria
    Jimenez-Morales, Alberto
    [J]. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2020, 785
  • [23] Long-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosis
    Portaccio, E
    Zipoli, V
    Siracusa, G
    Sorbi, S
    Amato, MP
    [J]. MULTIPLE SCLEROSIS, 2005, 11 : S158 - S158
  • [24] Single nucleotide polymorphisms in relapsing-remitting multiple sclerosis in Serbian patients: Disease susceptibility and interferon beta treatment response biomarkers
    Markovic, Milos
    Savic, Emina
    Popadic, Dusan
    Pravica, Vera
    Ramic, Zorica
    Drulovic, Jelena
    Stojkovic, Marija Mostarica
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 20 - 21
  • [25] Interferon-β in the treatment of relapsing-remitting multiple sclerosis
    Revel, M
    [J]. PHARMACOLOGY & THERAPEUTICS, 2003, 100 (01) : 49 - 62
  • [26] Response to interferon-beta therapy in relapsing-remitting multiple sclerosis: a comparison of different clinical criteria
    Portaccio, E
    Zipoli, V
    Siracusa, G
    Sorbi, S
    Amato, MP
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2006, 12 (03) : 281 - 286
  • [27] Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis
    Etemadifar, Masoud
    Janghorbani, Mohsen
    Shaygannejad, Vahid
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 (12) : 1723 - 1728
  • [28] Interferon beta-1a in relapsing-remitting multiple sclerosis
    Blumhardt, L
    [J]. HOSPITAL MEDICINE, 1999, 60 (03): : 192 - 195
  • [29] Brain atrophy as a non-response predictor to interferon-beta in relapsing-remitting multiple sclerosis
    Ignacio Rojas, Juan
    Patrucco, Liliana
    Miguez, Jimena
    Besada, Cristina
    Cristiano, Edgardo
    [J]. NEUROLOGICAL RESEARCH, 2014, 36 (07) : 615 - 618
  • [30] Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis
    M. Etemadifar
    M. Janghorbani
    V. Shaygannejad
    [J]. Journal of Neurology, 2007, 254
12345